Arctostaphylos uva-ursi leaf

Last content change Mar 27, 2020checked dailysee data sync status

This product has been discontinued

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Active ingredient: Arctostaphylos Uva-Ursi Leaf 1 [hp_X]
Other brand names: Uva Ursi (by Boiron)
Uva Ursi (by Boiron)
Uva Ursi (by Boiron)
Uva Ursi (by Boiron)
Uva Ursi (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
View full label-group details →
Dosage form: Pellet
Route: Oral
Prescription status: Homeopathic
Marketed in the U.S.: Since 2015
Label revision date: March 27, 2020
Manufacturer Document: Prescribing information, PDF file

Active ingredient: Arctostaphylos Uva-Ursi Leaf 1 [hp_X]
Other brand names: Uva Ursi (by Boiron)
Uva Ursi (by Boiron)
Uva Ursi (by Boiron)
Uva Ursi (by Boiron)
Uva Ursi (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
View full label-group details →
Dosage form: Pellet
Route: Oral
Prescription status: Homeopathic
CSA schedule: Not a scheduled drug
Marketed in the U.S.: Since 2015
Label revision date: March 27, 2020
Manufacturer: Rxhomeo Private Limited d. b. a. Rxhomeo, Inc
NDC root: 15631-0452
Manufacturer Document: Prescribing information, PDF file

Packaging Info (6 NDCs)

Packaging & NDC Codes (6)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

You may be wondering about a medication that is used for specific conditions as directed by your physician. This drug is designed to help manage certain health issues effectively, although the exact conditions it treats are not specified here.

If you have any questions about how this medication might work for you or its specific uses, it's best to consult with your healthcare provider for personalized information and guidance.

Uses

You may use this medication for the condition specified by your doctor or as directed by them. It's important to follow your healthcare provider's instructions to ensure the best outcome for your health.

This medication has been noted to have no teratogenic effects (which means it does not cause birth defects) or nonteratogenic effects, making it a safe option in those respects. Always consult with your physician for personalized advice and information regarding your treatment.

Dosage and Administration

When taking this medication, adults should take either 4 or 6 pellets by mouth three times a day, or follow your doctor's specific recommendations. If you are giving this medication to a child who is 2 years or older, they should take half of the adult dose.

Make sure to follow these guidelines closely to ensure the best results from your treatment. If you have any questions or concerns about the dosage, don’t hesitate to reach out to your healthcare provider for clarification.

Warnings and Precautions

This product is intended for short-term use to help with self-limiting conditions, meaning it should only be used for issues that typically resolve on their own. If your symptoms do not improve within four days or if they worsen, it’s important to stop using the product and consult a healthcare professional for further guidance.

If you are pregnant or nursing, please seek advice from a healthcare provider before using this medication. Always keep this and all medications out of reach of children to prevent accidental ingestion. Additionally, do not use the product if the cap seal is broken or missing, and remember to close the cap tightly after each use to maintain its effectiveness.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the effects of an overdose for this medication, you should be aware of general signs that may indicate a problem. These can include unusual drowsiness, confusion, or difficulty breathing.

If you notice any of these symptoms or if you believe you have taken too much of the medication, seek medical help right away. Contact your healthcare provider or go to the nearest emergency room. It's always better to be safe and get checked out if you have any concerns about your health.

Storage and Handling

To ensure the best performance and safety of your product, store it in a cool, dark place. This helps maintain its effectiveness and prevents any degradation that could occur from exposure to light or heat.

When handling the product, always ensure that your hands are clean to avoid contamination. If there are any specific components included with the product, make sure to follow any additional instructions provided for their use or disposal. Proper storage and handling are key to ensuring your product remains safe and effective.

Additional Information

This product is taken orally and is intended for self-limiting conditions, meaning it should help with symptoms that typically resolve on their own. If your symptoms do not improve within four days or if they worsen, you should stop using the product and consult a healthcare professional.

If you are pregnant or nursing, it's important to seek advice from a healthcare provider before using this medication. Always keep this and all medications out of reach of children, and do not use the product if the cap seal is broken or missing. Remember to close the cap tightly after each use to ensure safety.

FAQ

What conditions is this product used for?

This product is used for the condition listed above or as directed by your physician.

What is the recommended dosage for adults?

Adults should take 4 or 6 pellets by mouth, three times daily or as suggested by your physician.

What is the recommended dosage for children?

Children 2 years and older should take half the adult dose.

What should I do if my symptoms do not improve?

If your symptoms do not improve in 4 days or worsen, discontinue use and seek assistance from a health professional.

Is this product safe to use during pregnancy or while nursing?

As with any drug, if you are pregnant or nursing a baby, seek professional advice before taking this product.

How should I store this medication?

Store this product in a cool, dark place.

What precautions should I take when using this product?

Keep this and all medication out of reach of children, do not use if the cap seal is broken or missing, and close the cap tightly after use.

What are the teratogenic effects of this product?

No teratogenic effects (causing malformation of an embryo or fetus) are mentioned.

What are the nonteratogenic effects of this product?

No nonteratogenic effects are mentioned.

Packaging Info

This section summarizes the homeopathic presentations of Uva Ursi. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Uva Ursi.

	100 in vial, single-dose 100 items total	Pellet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients sucrose
	200 in package 200 items total	Pellet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients sucrose
	400 in package 400 items total	Pellet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients sucrose
	750 in package 750 items total	Pellet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients sucrose
	2500 in package 2500 items total	Pellet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients sucrose
	12500 in package 12500 items total	Pellet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients sucrose

Manufacturer Insert (PDF)

This file includes usage instructions and other product details provided by the manufacturer. This is not an FDA-approved drug.

View manufacturer document (PDF)

Description

Description:

This product contains UVA URSI HPUS 1X and higher as the active ingredient, derived from the leaf of Arctostaphylos uva-ursi (UNII: 3M5V3D1X36). The formulation includes sucrose as an inactive ingredient. It is classified as a human over-the-counter (OTC) drug and is intended for oral administration. The strength of the active ingredient is 1 hp_X.

Packaging & NDC

This section summarizes the homeopathic presentations of Uva Ursi. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Uva Ursi.

	100 in vial, single-dose 100 items total	Pellet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients sucrose
	200 in package 200 items total	Pellet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients sucrose
	400 in package 400 items total	Pellet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients sucrose
	750 in package 750 items total	Pellet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients sucrose
	2500 in package 2500 items total	Pellet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients sucrose
	12500 in package 12500 items total	Pellet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients sucrose

Manufacturer Insert (PDF)

This is the product document submitted by Rxhomeo Private Limited d. b. a. Rxhomeo, Inc for Uva Ursi. It includes information on ingredients, suggested use, and labeling language. This product is not FDA-approved.

View product insert (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the manufacturer-supplied FDA Structured Product Label (DailyMed) for Uva Ursi, retrieved February 17, 2026 by a validated AI data-extraction workflow.

All dosage forms and strengths provided by the manufacturer are listed in the Packaging & NDC Codes section above.

Homeopathic drug products are not reviewed by FDA for safety or effectiveness; information is reproduced without modification.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update: February 17, 2026

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.